Angiotensin-converting enzyme gene single polymorphism as a genetic biomarker of diabetic peripheral neuropathy: Longitudinal prospective study

Journal of Diabetes and its Complications

Volumn 26, Issue 2, 2012, Pages 77-82

  Jurado, J ^a   Ybarra, J ^b   Romeo, J H ^c   Garcia, M ^d   Zabaleta Del Olmo, E ^e  

^a INSTITUT UNIVERSITARI D'INVESTIGACIÓ EN ATENCIÓ PRIMÀRIA JORDI GOL   (Spain)

^b CENTRO MÉDICO TEKNON   (Spain)

^c BALDWIN WALLACE COLLEGE   (United States)

^d IDIAP Jordi Gol   (Spain)

^e Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

Author keywords

Angiotensin converting enzyme (ACE) gene polymorphism; Diabetic peripheral neuropathy (DPN); Type 2 diabetes mellitus (T2DM)

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CORRELATION ANALYSIS; DIABETIC NEUROPATHY; FEMALE; GENDER; GENETIC MARKER; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL ANALYSIS;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; GENETIC MARKERS; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUTATION; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84860679401     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.02.011     Document Type: Article

References (44)

1. A.J. Boulton, and L. Vileikyte The diabetic foot: the scope of the problem Journal of Family Practice 49 2000 S3 S8
2. K.P. Burdon, C.D. Langefeld, L.E. Wagenknecht, J.J. Carr, B.I. Freedman, and D. Herrington Association analysis of genes in the renin-angiotensin system with subclinical cardiovascular disease in families with type 2 diabetes mellitus: the Diabetes Heart Study Diabetic Medicine 23 2006 228 234
3. G. Cermenati, S. Giatti, G. Cavaletti, R. Bianchi, O. Maschi, and M. Pesaresi Activation of the liver X receptor increases neuroactive steroid levels and protects from diabetes-induced peripheral neuropathy Journal of Neuroscience 30 2010 11896 11901
4. H.C. Cho The association between serum GGT concentration and diabetic peripheral polyneuropathy in type 2 diabetic patients Korean Diabetes Journal 34 2010 111 118
5. T. Costacou, Y. Chang, R.E. Ferrell, and T.J. Orchard Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: an application of tree-structured survival analysis American Journal of Epidemiology 164 2006 862 872 (Pubitemid 44627271)
6. A.B. Gaikwad, J. Gupta, and K. Tikoo Epigenetic changes and alteration of Fbn1 and Col3A1 gene expression under hyperglycaemic and hyperinsulinaemic conditions Biochemical Journal 432 2010 333 341
7. K.C. Gorson, and A.H. Ropper Additional causes for distal sensory polyneuropathy in diabetic patients Journal of Neurology Neurosurgery and Psychiatry 77 2006 354 358
8. S.E. Holzer, A. Camerota, L. Martens, T. Cuerdon, J. Crystal-Peters, and M. Zagari Costs and duration of care for lower extremity ulcers in patients with diabetes Clinical Therapeutics 20 1998 169 181 (Pubitemid 28126290)
9. T.S. Ikonen, R. Sund, M. Venermo, and K. Winell Fewer major amputations among individuals with diabetes in Finland in 1997-2007: a population-based study Diabetes Care 33 2010 2598 2603
10. H. Ito, S. Tsukui, T. Kanda, T. Utsugi, T. Ohno, and M. Kurabayashi Angiotensin-converting enzyme insertion/detection polymorphism and polyneuropathy in type 2 diabetes without macroalbuminuria Journal of International Medical Research 30 2002 476 482 (Pubitemid 35282672)
11. J. Jurado, J. Caula, and J.M. Pou Selection of risk and diagnosis in diabetic polyneuropathy. validation of method of new systems Atencion Primaria 30 2006 116 121 (Pubitemid 44204757)
12. J. Jurado, M. Pastoret, J. Ybarra, I. Gich, and J.M. Pou Cardiovascular disease, diabetic polyneuropathy and ACE GENE POLYMORPHISMS IN the North Catalonia Diabetes Study (NCDS) Diabetologia 49 2006 1 755 664 (Es un poster, hay un error en el número de pagina, yo no lo pondría)
13. J. Jurado, J. Ybarra, J.H. Romeo, and J.M. Pou Clinical screening and diagnosis of diabetic polyneuropathy: the North Catalonia Diabetes Study European Journal of Clinical Investigation 39 2009 183 189
14. H. Kamiya, W. Zhang, and A.A. Sima The beneficial effects of C-peptide on diabetic polyneuropathy Reviews on Diabetes Study 6 2009 187 202
15. T. Klemm, and R. Paschke Possible genetic causes for late complications of diabetes mellitus Medizinische Klinik (Munich) 95 2000 31 39 (Pubitemid 30064569)
16. V.K. Kolla, G. Madhavi, B. Pulla Reddy, B.M. Srikanth Babu, J. Yashovanthi, and V.L. Valluri Association of tumor necrosis factor alpha, interferon gamma and interleukin 10 gene polymorphisms with peripheral neuropathy in South Indian patients with type 2 diabetes Cytokine 47 2009 173 177
17. G. Lee, Z. Xiang, T.H. Brannagan III, R.L. Chin, and N. Latov Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies Journal of the Neurological Sciences 290 2010 115 122
18. A. López-de-Andrés, M.A. Martínez-Huedo, P. Carrasco-Garrido, V. Hernández-Barrera, A. Gil-de-Miguel, and R. Jiménez-García Trends in lower-extremity amputations in people with and without diabetes in Spain, 2001-2008 Diabetes Care 34 2011 1570 1576
19. J.A. Mayfield, G.E. Reiber, L.J. Sanders, D. Janisse, and L.M. Pogach Preventive foot care in people with diabetes Diabetes Care 21 1998 2161 2177 (Pubitemid 28549168)
20. I.G. Obrosova, R. Stavniichuk, V.R. Drel, H. Shevalye, I. Vareniuk, and J.L. Nadler Different roles of 12/15-lipoxygenase in diabetic large and small fiber peripheral and autonomic neuropathies American Journal of Pathology 177 2010 1436 1447
21. OECD Avoidable admissions: diabetes complications OECD Health at a glance 2009: OECD indicators 2009 OECD Publishing 118 119 [cited July 29, 2011]. Avalaible in http://www.oecd-ilibrary.org/avoidable-admissions-diabetes- complications-5ks5mgftfbzw.pdf?contentType=/ns/Chapter,/ns/ StatisticalPublication&itemId=/content/chapter/health-glance-2009-49- en&containerItemId=/content/serial/19991312&accessItemIds=&mimeType= application/pdf
22. N. Papanas, K. Papatheodorou, D. Papazoglou, S. Kotsiou, D. Christakidis, and E. Maltezos An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with peripheral neuropathy in patients with type 2 diabetes mellitus Experimental and Clinical Endocrinology & Diabetes 115 2007 327 330 (Pubitemid 46877867)
23. S.A. Price, C. Dent, B. Duran-Jimenez, Y. Liang, L. Zhang, and E.J. Rebar Gene transfer of an engineered transcription factor promoting expression of VEGF-A protects against experimental diabetic neuropathy Diabetes 55 2006 1847 1854 (Pubitemid 44324142)
24. A.H. Ropper, K.C. Gorson, C.L. Gooch, D.H. Weinberg, A. Pieczek, and J.H. Ware Vascular endothelial growth factor gene transfer for diabetic polyneuropathy: a randomized, double-blinded trial Annals of Neurology 65 2009 386 393
25. G. Rudofsky Jr, P. Reismann, S. Witte, P.M. Humpert, B. Isermann, and T. Chavakis Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes Diabetes Care 27 2004 179 183 (Pubitemid 38196729)
26. M.L. Sands, S.M. Shetterly, G.M. Franklin, and R.F. Hamman Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study Diabetes Care 20 1997 322 329 (Pubitemid 27098218)
27. K.E. Schemmel, R.S. Padiyara, and J.J. D'Souza Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review Journal of Diabetes and its Complications 24 2010 354 360
28. K. Sivenius, J. Pihlajamaki, J. Partanen, L. Niskanen, M. Laakso, and M. Uusitupa Aldose reductase gene polymorphisms and peripheral nerve function in patients with type 2 diabetes Diabetes Care 27 2004 2021 2026 (Pubitemid 38989249)
29. A.G. Smith, J. Russell, E.L. Feldman, J. Goldstein, A. Peltier, and S. Smith Lifestyle intervention for pre-diabetic neuropathy Diabetes Care 29 2006 1294 1299 (Pubitemid 44125925)
30. J.W. Stephens, S.S. Dhamrait, J. Acharya, S.E. Humphries, and S.J. Hurel A common variant in the ACE gene is associated with peripheral neuropathy in women with type 2 diabetes mellitus Journal of Diabetes and its Complications 20 2006 317 321 (Pubitemid 44292531)
31. Y. Suzuki, M. Taniyama, T. Muramatsu, S. Higuchi, S. Ohta, and Y. Atsumi ALDH2/ADH2 polymorphism associated with vasculopathy and neuropathy in type 2 diabetes Alcoholism Clinical and Experimental Research 28 2004 111S 116S (Pubitemid 44139571)
32. A.A. Tahrani, T. Askwith, and M.J. Stevens Emerging drugs for diabetic neuropathy Expert Opinion on Emerging Drugs 15 2010 661 683
33. R.J. Tapp, J.E. Shaw, M.P. De Courten, D.W. Dunstan, T.A. Welborn, and P.Z. Zimmet Foot complications in type 2 diabetes: an Australian population-based study Diabetic Medicine 20 2003 105 113 (Pubitemid 36269651)
34. S. Tesfaye, N. Chaturvedi, S.E. Eaton, J.D. Ward, C. Manes, and C. Ionescu-Tirgoviste Vascular risk factors and diabetic neuropathy New England Journal of Medicine 352 2005 341 350
35. S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, and P. Kempler Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments Diabetes Care 33 2010 2285 2293
36. C. Tian, S. Fang, X. Du, and C. Jia Association of the C47T polymorphism in SOD2 with diabetes mellitus and diabetic microvascular complications: a meta-analysis Diabetologia 54 2011 803 811
37. UK Prospective Diabetes Study Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
38. E.P. Vamos, A. Bottle, M.E. Edmonds, J. Valabhji, A. Majeed, and C. Millett Changes in the incidence of lower extremity amputations in individuals with and without diabetes in England between 2004 and 2008 Diabetes Care 33 2010 2592 2597
39. A.I. Vinik, T. Erbas, T.S. Park, K.B. Stansberry, J.A. Scanelli, and G.L. Pittenger Dermal neurovascular dysfunction in type 2 diabetes Diabetes Care 24 2001 1468 1475 (Pubitemid 33716439)
40. V. Volarevic, N. Arsenijevic, M.L. Lukic, and M. Stojkovic Mesenchymal stem cell treatment of complications of diabetes mellitus Stem Cells 29 2010 5 10
41. Z. Wu, M. Mata, and D.J. Fink Prevention of diabetic neuropathy by regulatable expression of HSV-mediated erythropoietin Molecular Therapy 19 2011 310 317
42. H. Yamasaki, H. Sasaki, K. Ogawa, T. Shono, S. Tamura, and A. Doi Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients Diabetes Care 29 2006 888 894 (Pubitemid 44115312)
43. J. Ybarra, J.M. Pou, J.H. Romeo, J. Mercé, and J. Jurado Transforming growth factor 1 (TGFB1) as a biomarker of diabetic peripheral neuropathy: cross-sectional study Journal of Diabetes and its Complications 24 2010 306 312
44. S. Yesil, B. Akinci, F. Bayraktar, H. Havitcioglu, O. Karabay, and N. Yapar Reduction of major amputations after starting a multidisciplinary diabetic foot care team: single centre experience from Turkey Experimental and Clinical Endocrinology & Diabetes 117 2009 345 349